Tectonic Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Tectonic Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42M	Sell	5,896 -56	-0.9%	-$12.3K	0.07%	152
2026 Q1	$1.13M	Buy	5,952 +292	+5%	+$51K	0.06%	155
2025 Q4	$962K	Buy	5,660 +34	+0.6%	+$5.21K	0.05%	173
2025 Q3	$742K	Buy	5,626 +82	+1%	+$9.84K	0.04%	196
2025 Q2	$588K	Buy	5,544 +927	+20%	+$101K	0.03%	232
2025 Q1	$573K	Buy	4,617 +243	+6%	+$31.7K	0.04%	222
2024 Q4	$539K	Buy	4,374 +483	+12%	+$56.9K	0.04%	226
2024 Q3	$433K	Buy	3,891 +232	+6%	+$25.4K	0.03%	258
2024 Q2	$391K	Buy	3,659 +429	+13%	+$47.2K	0.03%	261
2024 Q1	$389K	Buy	3,230 +540	+20%	+$66.1K	0.03%	246
2023 Q4	$331K	Buy	2,690 +283	+12%	+$35.3K	0.03%	248
2023 Q3	$312K	Buy	+2,407	New	+$321K	0.03%	232

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tectonic Advisors's JAZZ Position: Q2 2026 in Review

Tectonic Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.94% in Q2 2026, selling an estimated $12.3K and leaving 5,896 shares worth $1.42M. The position accounts for 0.07% of the portfolio, ranked #152.

Tectonic Advisors first reported a position in JAZZ in Q3 2023 and has held it in 12 quarters since. 92 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Tectonic Advisors held 5,896 shares of Jazz Pharmaceuticals worth $1.42M as of Q2 2026.
Tectonic Advisors sold 56 Jazz Pharmaceuticals shares in Q2 2026, an estimated $12.3K.
Jazz Pharmaceuticals made up 0.07% of Tectonic Advisors's portfolio in Q2 2026, its #152 holding.
Tectonic Advisors first reported a position in Jazz Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
92 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Tectonic Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.